1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Farooq, A. Zhou, M.-M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 11 155 164 10.1016/S0969-2126(02)00943-7 12575935 Solution Structure of the MAPK Phosphatase PAC-1 Catalytic Domain Insights into Substrate-Induced Enzymatic Activation of MKP 2003 10.2210/pdb1m3g/pdb pdb_00001m3g 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 16129.417 DUAL SPECIFICITY PROTEIN PHOSPHATASE 2 3.1.3.48, 3.1.3.16 CATALYTIC DOMAIN, RESIDUES 170-314 C257S 1 man polymer MAPK Phosphatase PAC-1, DUAL SPECIFICITY PROTEIN PHOSPHATASE PAC-1 no no QGGPVEILPYLFLGSCSHSSDLQGLQACGITAVLNVSASCPNHFEGLFRYKSIPVEDNQMVEISAWFQEAIGFIDWVKNS GGRVLVHSQAGISRSATICLAYLMQSRRVRLDEAFDFVKQRRGVISPNFSFMGQLLQFETQVLCH QGGPVEILPYLFLGSCSHSSDLQGLQACGITAVLNVSASCPNHFEGLFRYKSIPVEDNQMVEISAWFQEAIGFIDWVKNS GGRVLVHSQAGISRSATICLAYLMQSRRVRLDEAFDFVKQRRGVISPNFSFMGQLLQFETQVLCH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli plasmid pET15b database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-06-27 1 1 2008-04-28 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details 2004-02-03 SPRSDE RCSB Y RCSB 2002-06-27 REL THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY 200 1 3D_13C-SEPARATED_NOESY 3D_ 15N-SEPARATED_NOESY HNHA 10 6.5 1 atm 298 K simulated annealing 0.5MM CATALYTIC DOMAIN MAPK PHOSPHATASE U-15N,13C; 5MM PHOSPHATE BUFFER PH 6.5 BRUNGER (X-PLOR), NILGES, O'DONOGHUE (ARIA) structure solution XPLOR/ARIA collection XwinNMR processing NMRPipe data analysis NMRView BRUNGER (X-PLOR)/ NILGES, O'DONOGHUE (ARIA) refinement XPLOR/ARIA 500 Bruker DRX 600 Bruker DRX GLN 170 n 1 GLN 170 A GLY 171 n 2 GLY 171 A GLY 172 n 3 GLY 172 A PRO 173 n 4 PRO 173 A VAL 174 n 5 VAL 174 A GLU 175 n 6 GLU 175 A ILE 176 n 7 ILE 176 A LEU 177 n 8 LEU 177 A PRO 178 n 9 PRO 178 A TYR 179 n 10 TYR 179 A LEU 180 n 11 LEU 180 A PHE 181 n 12 PHE 181 A LEU 182 n 13 LEU 182 A GLY 183 n 14 GLY 183 A SER 184 n 15 SER 184 A CYS 185 n 16 CYS 185 A SER 186 n 17 SER 186 A HIS 187 n 18 HIS 187 A SER 188 n 19 SER 188 A SER 189 n 20 SER 189 A ASP 190 n 21 ASP 190 A LEU 191 n 22 LEU 191 A GLN 192 n 23 GLN 192 A GLY 193 n 24 GLY 193 A LEU 194 n 25 LEU 194 A GLN 195 n 26 GLN 195 A ALA 196 n 27 ALA 196 A CYS 197 n 28 CYS 197 A GLY 198 n 29 GLY 198 A ILE 199 n 30 ILE 199 A THR 200 n 31 THR 200 A ALA 201 n 32 ALA 201 A VAL 202 n 33 VAL 202 A LEU 203 n 34 LEU 203 A ASN 204 n 35 ASN 204 A VAL 205 n 36 VAL 205 A SER 206 n 37 SER 206 A ALA 207 n 38 ALA 207 A SER 208 n 39 SER 208 A CYS 209 n 40 CYS 209 A PRO 210 n 41 PRO 210 A ASN 211 n 42 ASN 211 A HIS 212 n 43 HIS 212 A PHE 213 n 44 PHE 213 A GLU 214 n 45 GLU 214 A GLY 215 n 46 GLY 215 A LEU 216 n 47 LEU 216 A PHE 217 n 48 PHE 217 A ARG 218 n 49 ARG 218 A TYR 219 n 50 TYR 219 A LYS 220 n 51 LYS 220 A SER 221 n 52 SER 221 A ILE 222 n 53 ILE 222 A PRO 223 n 54 PRO 223 A VAL 224 n 55 VAL 224 A GLU 225 n 56 GLU 225 A ASP 226 n 57 ASP 226 A ASN 227 n 58 ASN 227 A GLN 228 n 59 GLN 228 A MET 229 n 60 MET 229 A VAL 230 n 61 VAL 230 A GLU 231 n 62 GLU 231 A ILE 232 n 63 ILE 232 A SER 233 n 64 SER 233 A ALA 234 n 65 ALA 234 A TRP 235 n 66 TRP 235 A PHE 236 n 67 PHE 236 A GLN 237 n 68 GLN 237 A GLU 238 n 69 GLU 238 A ALA 239 n 70 ALA 239 A ILE 240 n 71 ILE 240 A GLY 241 n 72 GLY 241 A PHE 242 n 73 PHE 242 A ILE 243 n 74 ILE 243 A ASP 244 n 75 ASP 244 A TRP 245 n 76 TRP 245 A VAL 246 n 77 VAL 246 A LYS 247 n 78 LYS 247 A ASN 248 n 79 ASN 248 A SER 249 n 80 SER 249 A GLY 250 n 81 GLY 250 A GLY 251 n 82 GLY 251 A ARG 252 n 83 ARG 252 A VAL 253 n 84 VAL 253 A LEU 254 n 85 LEU 254 A VAL 255 n 86 VAL 255 A HIS 256 n 87 HIS 256 A SER 257 n 88 SER 257 A GLN 258 n 89 GLN 258 A ALA 259 n 90 ALA 259 A GLY 260 n 91 GLY 260 A ILE 261 n 92 ILE 261 A SER 262 n 93 SER 262 A ARG 263 n 94 ARG 263 A SER 264 n 95 SER 264 A ALA 265 n 96 ALA 265 A THR 266 n 97 THR 266 A ILE 267 n 98 ILE 267 A CYS 268 n 99 CYS 268 A LEU 269 n 100 LEU 269 A ALA 270 n 101 ALA 270 A TYR 271 n 102 TYR 271 A LEU 272 n 103 LEU 272 A MET 273 n 104 MET 273 A GLN 274 n 105 GLN 274 A SER 275 n 106 SER 275 A ARG 276 n 107 ARG 276 A ARG 277 n 108 ARG 277 A VAL 278 n 109 VAL 278 A ARG 279 n 110 ARG 279 A LEU 280 n 111 LEU 280 A ASP 281 n 112 ASP 281 A GLU 282 n 113 GLU 282 A ALA 283 n 114 ALA 283 A PHE 284 n 115 PHE 284 A ASP 285 n 116 ASP 285 A PHE 286 n 117 PHE 286 A VAL 287 n 118 VAL 287 A LYS 288 n 119 LYS 288 A GLN 289 n 120 GLN 289 A ARG 290 n 121 ARG 290 A ARG 291 n 122 ARG 291 A GLY 292 n 123 GLY 292 A VAL 293 n 124 VAL 293 A ILE 294 n 125 ILE 294 A SER 295 n 126 SER 295 A PRO 296 n 127 PRO 296 A ASN 297 n 128 ASN 297 A PHE 298 n 129 PHE 298 A SER 299 n 130 SER 299 A PHE 300 n 131 PHE 300 A MET 301 n 132 MET 301 A GLY 302 n 133 GLY 302 A GLN 303 n 134 GLN 303 A LEU 304 n 135 LEU 304 A LEU 305 n 136 LEU 305 A GLN 306 n 137 GLN 306 A PHE 307 n 138 PHE 307 A GLU 308 n 139 GLU 308 A THR 309 n 140 THR 309 A GLN 310 n 141 GLN 310 A VAL 311 n 142 VAL 311 A LEU 312 n 143 LEU 312 A CYS 313 n 144 CYS 313 A HIS 314 n 145 HIS 314 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N VAL 174 A N VAL 5 A O LEU 182 A O LEU 13 A N PHE 181 A N PHE 12 A O VAL 253 A O VAL 84 A O LEU 254 A O LEU 85 A N LEU 203 A N LEU 34 A N VAL 202 A N VAL 33 A O ARG 218 A O ARG 49 A O TYR 219 A O TYR 50 A N PHE 213 A N PHE 44 1 A LEU 177 54.38 174.85 1 A SER 184 -172.23 -63.09 1 A CYS 185 -110.80 -151.57 1 A THR 200 -124.02 -61.68 1 A ASN 204 -68.56 90.86 1 A VAL 205 -69.85 78.50 1 A SER 206 -125.34 -77.30 1 A ALA 207 -170.88 -143.58 1 A CYS 209 50.29 -175.58 1 A PRO 210 -57.92 84.99 1 A HIS 212 -116.49 74.40 1 A GLU 214 -175.10 59.35 1 A PHE 217 -168.56 -79.06 1 A GLN 228 55.03 -87.89 1 A MET 229 -149.21 27.92 1 A VAL 230 53.71 101.37 1 A SER 249 -149.99 -49.68 1 A GLN 258 -155.02 21.43 1 A ALA 259 -173.05 29.85 1 A ARG 279 55.68 165.93 1 A LYS 288 -171.11 -171.28 1 A ARG 290 -64.12 -154.53 1 A ARG 291 54.58 95.97 1 A SER 295 54.29 173.83 1 A PRO 296 -63.88 99.80 1 A ASN 297 -162.38 39.27 1 A LEU 304 -157.83 -69.20 1 A LEU 312 -88.90 -74.37 SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF MAPK PHOSPHATASE PAC-1: INSIGHTS INTO SUBSTRATE-INDUCED ENZYMATIC ACTIVATION 1 N N A HIS 187 A HIS 18 HELX_P A GLY 198 A GLY 29 1 1 12 A TRP 235 A TRP 66 HELX_P A SER 249 A SER 80 1 2 15 A SER 262 A SER 93 HELX_P A SER 275 A SER 106 1 3 14 A VAL 278 A VAL 109 HELX_P A LYS 288 A LYS 119 1 4 11 A LEU 304 A LEU 135 HELX_P A LEU 312 A LEU 143 1 5 9 HYDROLASE CATALYTIC DOMAIN, MAPK PHOSPHATASE, PAC-1, HYDROLASE DUS2_HUMAN UNP 1 1 Q05923 MGLEAARELECAALGTLLRDPREAERTLLLDCRPFLAFCRRHVRAARPVPWNALLRRRARGPPAAVLACLLPDRALRTRL VRGELARAVVLDEGSASVAELRPDSPAHVLLAALLHETRAGPTAVYFLRGGFDGFQGCCPDLCSEAPAPALPPTGDKTSR SDSRAPVYDQGGPVEILPYLFLGSCSHSSDLQGLQACGITAVLNVSASCPNHFEGLFRYKSIPVEDNQMVEISAWFQEAI GFIDWVKNSGGRVLVHCQAGISRSATICLAYLMQSRRVRLDEAFDFVKQRRGVISPNFSFMGQLLQFETQVLCH 170 314 1M3G 170 314 Q05923 A 1 1 145 1 CYS engineered mutation SER 257 1M3G A Q05923 UNP 257 88 6 anti-parallel parallel parallel parallel anti-parallel A VAL 174 A VAL 5 A ILE 176 A ILE 7 A LEU 180 A LEU 11 A LEU 182 A LEU 13 A VAL 253 A VAL 84 A VAL 255 A VAL 86 A ALA 201 A ALA 32 A ASN 204 A ASN 35 A ARG 218 A ARG 49 A SER 221 A SER 52 A ASN 211 A ASN 42 A PHE 213 A PHE 44